Grifols (GIKLY) Non-Current Debt (2010 - 2025)

Grifols (GIKLY) reported Non-Current Debt of $10.6 billion for Q4 2025, up 4.34% on a YoY basis from $10.1 billion in Q4 2024, and up 4.34% quarter-over-quarter from $10.1 billion in Q4 2024.

Grifols (GIKLY) Non-Current Debt (2010 - 2025) Analysis & Trends

Grifols has reported Non-Current Debt for 16 years, with the latest figure at $10.6 billion in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt rose 4.34% year-over-year to $10.6 billion; the trailing twelve-month figure through Dec 2025 stood at $10.6 billion (up 4.34% YoY), and the FY2025 full-year result was $10.6 billion, up 4.34% from the prior year.
  • Non-Current Debt for Q4 2025 stood at $10.6 billion, up from $10.1 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $10.6 billion in Q4 2025, with the low at $875.9 million in Q4 2023.
  • Historically, Non-Current Debt has averaged $8.2 billion across 5 years, with a median of $10.1 billion in 2024.
  • Annual changes were most pronounced in 2023 — Non-Current Debt sank 91.48% — and 2024, when it soared 1057.91%.
  • Grifols' Non-Current Debt stood at $8.9 billion in 2021, then climbed by 15.65% to $10.3 billion in 2022, then slumped by 91.48% to $875.9 million in 2023, then soared by 1057.91% to $10.1 billion in 2024, then rose by 4.34% to $10.6 billion in 2025.
  • The last three Non-Current Debt figures came in at $10.6 billion (Q4 2025), $10.1 billion (Q4 2024), and $875.9 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -18.89 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 39.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 37.53 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 64.53 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 46.67 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 20.86 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 60.57 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 42.15 Bn
10 Grifols - - - 10.58 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.58 Bn
Dec 31, 2025 10.58 Bn
Dec 31, 2024 10.14 Bn
Dec 31, 2024 10.14 Bn
Dec 31, 2023 875.89 Mn
Dec 31, 2023 875.89 Mn
Dec 31, 2022 10.28 Bn
Dec 31, 2022 10.28 Bn
Dec 31, 2021 8.89 Bn
Dec 31, 2021 8.89 Bn
Dec 31, 2020 7.87 Bn
Dec 31, 2020 7.87 Bn
Sep 30, 2020 7.86 Bn
Sep 30, 2020 7.86 Bn
Mar 31, 2020 7.58 Bn
Mar 31, 2020 7.58 Bn
Dec 31, 2019 66.39 Mn
Dec 31, 2019 66.39 Mn
Sep 30, 2019 7.68 Bn
Sep 30, 2019 7.68 Bn